NorthWest Biotherapeutics Inc (NWBO)

[longusa]

On the new pool, I think we may see only 1 more; that would be on the day of the poster or the Friday before. The reason is that I'm guessing that NW has been surprised by the negative reaction to the 1st PR. Although I personally think it was fine - it was exactly the type of PR we have been looking for since the PhI was announced as unblinded, many observers seem to automatically think the worst of NW.

So, given there is only so much data from the PhI, the one release would be the data on the poster, which hopefully gives overall summary as well as case study info, i.e., by RECIST criteria, what has been the % of response types, by dose, and especially what degree of systemic response was seen (what has been the furthest distance from an injected tumor where regression in a non-injected tumor was seen).